Presentation materials
FY2024
December 4
Sustainability Meeting
October 28
FY2024 2Q Financial Results
July 29
FY2024 1Q Financial Results
June 12
R&D Day Follow-up Meeting
June 7
R&D Day
May 13
FY2023 Financial Results
FY2023
January 31
FY2023 3Q Financial Results
December 13
10th Mizuho Bio Conference
November 1
FY2023 2Q Financial Results
October 19
Sustainability Meeting
October 12
HIV Follow Up Meeting
September 19
ESWI 2023 Follow Up Meeting
July 31
FY2023 1Q Financial Results
June 1
Revision of the Medium-Term Business Plan STS2030
May 11
FY2022 Financial Results
Click here for past presentation materials
FY2022
March 30
HIV Business Meeting
February 22
CROI 2023 Follow Up Meeting
February 22
FY2022 the 30th CROI; Phase 3 part of Phase 2/3 trial result
January 30
FY2022 3Q Financial Results
November 24
Briefing Session onCOVID-19
November 1
FY2022 2Q Financial Results
October 12
R&D day
August 1
FY2022 1Q Financial Results
June 15
Press conference on the conclusion of landmark license and collaboration agreement by GARDP, CHAI and Shionogi
June 10
Goldman Sachs Japan Thought Leaders Forum 2022
May 11
FY2021 Financial Results
April 24
the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID); Results from clinical trials of S-217622
FY2021
March 4
SMBC Nikko Web IR for Retail Investors SMBC Nikko Web IR for Retail Investors
March 4
Briefing session on Phase 2/3 booster trial of COVID-19 vaccine "S-268019"
February 7
Briefing session on COVID-19 therapeutic drug "S-217622"
January 31
3Q Conference Call
November 1
FY2021 2Q Financial Results
September 29
R&D Meeting
September 16
BofA Global Healthcare Conference 2021
August 2
1Q Conference Call
FY2020
May 11
FY2020 Financial Results
February 1
FY2020 3Q Financial Results
November 2
FY2020 2Q Financial Results
October 13
Briefing Session on the Business of the Joint Venture with Ping An Group
July31
1Q Conference Call
June 1
2030 Vision and Medium-Term Business Plan "Shionogi Transformation Strategy (STS2030)"
FY2019
May 12
FY2019 Financial results
March 30
Strategic partnership with Ping An Insurance Company
March 19
R&D Meeting
February 3
3Q Conference Call
October 31
1st Half of Fiscal 2019 Financial Results
July 29
1Q Conference Call
May 10
Financial Results
FY2018
Presentation Materials
FY2017
Presentation Materials
FY2016
Presentation Materials
- Financial Results (May 11, 2017)
- Shionogi Inc.’s New Business Strategy (March 16, 2017)
- R&D Meeting (March 16, 2017)
- 3Q Conference Call (February 2, 2017)
- 1st Half of Financial Results (November 1, 2016)
- Updates to Shionogi Growth Strategy (SGS2020) (October 31, 2016)
- 1Q Conference Call (August 1, 2016)
Conference Materials
FY2015
Presentation Materials
Conference Materials
FY2014
Presentation Materials
Conference Materials
FY2013
Presentation Materials
FY2012
Presentation Materials
- Financial Results (May 10, 2013)
- R&D Meeting (March 19, 2013)
- 3Q Conference Call (February 4, 2013)
- 1st Half of Financial Results (November 5, 2012)
- New Agreement to Commercialize and Develop HIV Integrase Inhibitor Portfolio with ViiV Healthcare (October 29, 2012)
- 1Q Conference Call (August 6, 2012)